or BMI 27 kg/m with at least one indicator of increased cardiovascular risk (e.g., coronary heart disease, hypertension, dyslipidemia, diabetes, elevated waist circumference), or another obesity-related medical condition (e.g., sleep apnea)
Achari added that improvements seen by athletes like Serena Williams are probably downstream effects of losing weight and getting back into shape, rather than the drug providing any direct benefits to performance
However, whether this weight loss had a bad effect on OA rats remained to be further studied
Circulation 142:12051218
Glutathione Bioresponsive Cyclodextrin Nanosponges [PMID: 31968774] Laboratory literature summary: Glutathione Bioresponsive Cyclodextrin Nanosponges
Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice